Drugplain

GARDASIL 9 40 ug/.5mL

Human Papillomavirus 9-valent Vaccine, Recombinant · INJECTION, SUSPENSION · A-S Medication Solutions

No Recall History
Plain English

GARDASIL 9 is a injection, suspension containing human papillomavirus 9-valent vaccine, recombinant at 40 ug/.5mL, taken intramuscular. Manufactured by A-S Medication Solutions.

Key Facts

Brand Name
GARDASIL 9
Generic Name
Human Papillomavirus 9-valent Vaccine, Recombinant
NDC Code (Product)
50090-4958
Manufacturer
A-S Medication Solutions
Strength
40 ug/.5mL
Dosage Form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Marketing Status
Application #
BLA125508
Marketing Start
12/10/2014

Recall History

No Recall History

Frequently Asked Questions

What is GARDASIL 9 used for?

GARDASIL 9 contains Human Papillomavirus 9-valent Vaccine, Recombinant. It is a injection, suspension taken intramuscular. Consult your doctor for specific uses.

Is GARDASIL 9 a controlled substance?

GARDASIL 9 is not classified as a controlled substance by the DEA.

What is the generic name for GARDASIL 9?

The generic name for GARDASIL 9 is Human Papillomavirus 9-valent Vaccine, Recombinant. There are no other listed brand versions of Human Papillomavirus 9-valent Vaccine, Recombinant.

What is the NDC code for GARDASIL 9 40 ug/.5mL?

The NDC (National Drug Code) for GARDASIL 9 40 ug/.5mL is 50090-4958, listed by A-S Medication Solutions.

Product NDC

50090-4958

Package NDC

50090-4958-1

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)